China Pharma Holdings - 22 Year Stock Price History | CPHI

Historical daily share price chart and data for China Pharma Holdings since 2002 adjusted for splits and dividends. The latest closing stock price for China Pharma Holdings as of April 18, 2024 is 0.33.
  • The all-time high China Pharma Holdings stock closing price was 1880.00 on April 19, 2002.
  • The China Pharma Holdings 52-week high stock price is 2.69, which is 715.2% above the current share price.
  • The China Pharma Holdings 52-week low stock price is 0.30, which is 9.1% below the current share price.
  • The average China Pharma Holdings stock price for the last 52 weeks is 0.91.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
China Pharma Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 0.4234 0.5835 0.5890 0.3188 0.3277 -45.83%
2023 1.8935 4.3500 5.8450 0.4465 0.6050 -87.38%
2022 12.5062 22.9150 24.9750 4.7426 4.7950 -80.13%
2021 35.3760 24.5000 64.0000 20.5000 24.1300 8.25%
2020 23.8750 12.3750 57.0000 12.3750 22.2900 88.26%
2019 14.1793 12.0000 25.3500 11.1050 11.8400 -8.00%
2018 14.3820 8.6500 28.9950 8.5950 12.8700 46.58%
2017 10.6387 12.7100 14.5000 7.5000 8.7800 -32.46%
2016 10.5839 8.2100 15.9750 6.0000 13.0000 65.71%
2015 14.0063 15.5000 21.0000 7.7900 7.8450 -47.72%
2014 19.2798 18.0000 39.2500 10.2500 15.0050 -13.01%
2013 13.4908 13.0000 23.5000 9.5050 17.2500 70.79%
2012 22.5901 33.8000 41.0000 9.5000 10.1000 -69.85%
2011 99.0914 155.5000 156.5000 33.5000 33.5000 -77.89%
2010 153.5243 187.5000 206.0000 106.5000 151.5000 -21.30%
2009 105.5938 58.5000 196.5000 56.5000 192.5000 237.72%
2008 104.5453 147.5000 154.5000 55.0000 57.0000 -62.62%
2007 106.8593 112.5000 208.5000 67.5000 152.5000 34.36%
2006 73.7729 90.0000 117.5000 52.5000 113.5000 26.11%
2005 63.6151 20.0000 132.5000 17.5000 90.0000 350.00%
2004 52.1786 150.0000 150.0000 20.0000 20.0000 -86.67%
2003 333.5769 120.0000 510.0000 70.0000 150.0000 25.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.776B 5.34
Dr Reddy's Laboratories (RDY) India $11.900B 18.82
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Bausch Health Cos (BHC) Canada $3.164B 2.47
Amphastar Pharmaceuticals (AMPH) United States $1.957B 13.40
Supernus Pharmaceuticals (SUPN) United States $1.587B 0.00
Taysha Gene Therapies (TSHA) United States $0.458B 0.00
Generation Bio (GBIO) United States $0.198B 0.00
Assembly Biosciences (ASMB) United States $0.071B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.030B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00